Schedule 13G ownership disclosure

LAKEFRONT BIOTHERAPEUTICS NV

Security class unavailable · CUSIP: 36315X101

Event date: 2016-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
3,943,150
Percent of class
8.5000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-17-009567
Form type
SC 13G/A
Filer
Lakefront Biotherapeutics NV
CIK
CIK 1421876
Filed
Feb 15, 2017
Reporting period
Dec 31, 2016
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub